A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor Patients

Clinical trial NCT06985368 · RECRUITING

Trial details

NCT number: NCT06985368
Sponsor: Shanghai Institute Of Biological Products
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Malignancy

Start date: 2025-06-16
Primary completion: 2028-05-15
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.